Cargando…
Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
Drug resistance and poor treatment response are major obstacles to the effective treatment of acute myeloid leukemia (AML). A deeper understanding of the mechanisms regulating drug resistance and response genes in AML is therefore urgently needed. Our previous research has highlighted the important...
Autores principales: | Liu, Xin, Zhong, Shuxin, Qiu, Kangjie, Chen, Xi, Wu, Weiyue, Zheng, Jiamian, Liu, Yanwen, Wu, Haolong, Fan, Shiyun, Nie, Dingrui, Wang, Xianfeng, Yu, Zhi, Liao, Ziwei, Zhong, Mengjun, Li, Yangqiu, Zeng, Chengwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189915/ https://www.ncbi.nlm.nih.gov/pubmed/37198609 http://dx.doi.org/10.1186/s40164-023-00411-4 |
Ejemplares similares
-
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis
por: Nie, Dingrui, et al.
Publicado: (2022) -
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia
por: Yu, Xibao, et al.
Publicado: (2023) -
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
por: Zhong, Mengjun, et al.
Publicado: (2022) -
Correction to: BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
por: Zhong, Mengjun, et al.
Publicado: (2022) -
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis
por: Verma, Nandini, et al.
Publicado: (2020)